Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03696771 |
| Title | Study to Determine Safety and Dose of NJH395 in Non-breast HER2+ Advanced Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ITA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Novartis Investigative Site | Milano | MI | 20162 | Italy | Details | |
| Novartis Investigative Site | Kashiwa | Chiba | 277 8577 | Japan | Details | |
| Novartis Investigative Site | Seoul | 03080 | Korea, Republic of | Details |